New oral drug tested against blood fungus infection
Disease control
Terminated
This study tested a new oral medicine, ibrexafungerp, against the standard oral medicine fluconazole for treating serious fungal infections in the blood or body tissues. All participants first received an IV antifungal, then were randomly assigned to one of the two oral drugs. Th…
Phase: PHASE3 • Sponsor: Scynexis, Inc. • Aim: Disease control
Last updated May 14, 2026 12:01 UTC